ArticleBMJ open gastroenterology2020

Treatment persistence and colectomy-free outcomes in patients with ulcerative colitis receiving golimumab or adalimumab: a UK experience.

Sami Hoque et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.